Archondakis Stavros | Histopathology & Cytology | Research Excellence Award

Dr. Archondakis Stavros | Histopathology & Cytology | Research Excellence Award

Director | Alpha Prolipsis Medical Laboratories | Greece

Dr. Archondakis Stavros is is a researcher with a strong scholarly focus on cytopathology, telecytology, laboratory quality systems, and digital health applications in diagnostic pathology. His research portfolio encompasses 49 peer-reviewed documents, reflecting sustained contributions to international journals, edited volumes, and book chapters that address diagnostic accuracy, quality assurance, and the implementation of ISO 15189 standards in laboratory medicine. With an h-index of 9 and 313 citations, his work demonstrates measurable impact within the scientific community, particularly in advancing telecytology, mobile health technologies, and laboratory information systems. His publications frequently explore the integration of emerging technologies into cytopathology workflows, aiming to enhance diagnostic reliability, proficiency testing, and remote consultation. Through a consistent research output spanning methodological, applied, and translational studies, his scholarship has contributed to improving quality management practices and innovation in modern cytopathology and laboratory medicine.

Citation Metrics (Scopus)

400

300

200

100

0

 

313
Citations

48
Documents

9
h-index

Citations

Documents

h-index

Featured Publications

Hamid Madanchi | Bioinformatics in Lab Medicine | Editorial Board Member

Mr. Hamid Madanchi | Bioinformatics in Lab Medicine | Editorial Board Member

Assistant Professor | Semnan University of Medical Sciences | Iran

Dr. Hamid Madanchi, Ph.D., is an Assistant Professor of Pharmaceutical Biotechnology at the Semnan University of Medical Sciences and an active researcher at the Pasteur Institute of Iran. His multidisciplinary research integrates pharmaceutical biotechnology, bioinformatics, immunoinformatics, and peptide-based drug design to develop novel therapeutics and vaccines. With extensive expertise in molecular cloning, protein engineering, computational biology, and antimicrobial peptide synthesis, Dr. Madanchi’s work focuses on the discovery and rational design of bioactive peptides with anticancer, antimicrobial, and antiviral properties. His recent investigations include the development of SARS-CoV-2 fusion inhibitors, multi-epitope vaccines against emerging pathogens, and nanobiocomposite scaffolds for biomedical applications. Dr. Madanchi has authored and co-authored numerous peer-reviewed articles in high-impact journals such as Journal of Biomolecular Structure and Dynamics, Scientific Reports, Probiotics and Antimicrobial Proteins, and BMC Bioinformatics. His scientific contributions also include studies on peptide-based drug delivery systems, targeted cancer therapies, and computational vaccine design. As principal investigator on multiple national research projects, he has led efforts in epitope-based vaccine construction, antiviral peptide discovery, and bioinformatics-driven drug repurposing. Beyond research, Dr. Madanchi has played an important role in mentoring graduate students and advancing pharmaceutical biotechnology education in Iran. His ongoing work continues to bridge experimental and computational methods for the discovery of next-generation therapeutic biomolecules addressing global health challenges.

Profile: ORCID  

Featured Publications